Pharmacology Of Renal Neoplasia Flashcards Preview

Renal Course > Pharmacology Of Renal Neoplasia > Flashcards

Flashcards in Pharmacology Of Renal Neoplasia Deck (13)
Loading flashcards...

Kidney and renal cancer facts

6th most common cancer in men; 8th most common in women

Commonly diagnosed in 40-70s

Risk factors
- smoking
- obesity
- untreated HTN (especially if >150/90)
Family history

85% = renal call carcinomas
- most common subtype = clear cell


Clincial presentation of renal cancers

Classic triad (although only 10% present with this)
- flank pain
- hematuria
- palpable mass that cross midline


Staging of kidney cancers and overall survival %

Stage 1:
- only found in kidney
- low grade
- is less than 7cm in diameter
- 5 yr% = 96

Stage 2:
- only found in kidney
- low-mid grade
- > 7cm in diameter
- 5 yr% = 82

Stage 3:
Has spread to near by structures and surrounding fat (however has NOT crossed Geroat’s fascia)
- mid-high grade
- can be any size
- 5 yr % = 64

Stage 4:
- has spread past geroat’s fascia and is often metastatic to lungs and brain tissues
- high grade
- can be any size
- 5 yr% = 23


What are the most common metastasis sites for kidney cancers (renal cell carcinomas)?






Goals of therapy for RCC

Stage 1-3
- nephrectomy (+/-) chemo
- * 20-30% of patinets will release though within 2 yrs so need to monitor aggressively

Stage 4
- palliative care (+/-) aggressive chemo
- focus more on quality of life


How is chemotherapy divided in kidney cancer patients?

Based on whether it is clear cell histology on biopsy or not


Why does gemcitabine, vinblastine and 5-FU have such poor efficacy in RCC?

Due to very high levels of P-glycoprotein being present especially in RCC cases
- this protein functions as an energy dependent pump towards chemotherapy agents and other toxins

This induces drug resistance and is a product of up-regulation of the MDR1 gene


What is capillary leak syndorme

Rare disorder that can occur idiopathically or via drug exposure (usually biologics)

Casues capillary fenestrations to widen greatly, leading to hypotension, hypoalbuminemia, hemoconcentrations

Leads ultimately if untreated to overwhelming edema and shock levels of hypotension and stoppage of breathing

**must try to catch this if it starts to present since its highly fatal**


What are the first generation TK Inhibitors used in RCC?


- 2nd line in noval mRCC. Hardly used for refractory or advanced mRCC


**sunitinib and pazopanib are first line agents in noval mRCC and 2nd line in advanced or refractory**


What is the 2nd generation TK- inhibtor used for mRCC?


50-450x more potent and is first line in both noval mRCC and advanced/refractory mRCC


What is the hallmark for clear cell RCC?

Inactivation of VHL suppressor gene


What are the first line therapy options of mRCC non advanced?

Temisrolimus IV = only for high risk mRCC

Sunitinib, pazopanib and axitinib are the 1st line TK-Inhibitors


What are 2nd line agents reserved for only advanced mRCC/ refractory mRCC

Sorafenib and carbozantinib and everolimus